Login / Signup

Identification of the prognostic immune subtype in copy-number high endometrial cancer.

Mingyi MaoFang JiangRuiqin HanYang Xiang
Published in: Journal of gynecologic oncology (2023)
Our study revealed heterogeneous immune subtypes in CNH EC and identified GZMM as a prognostic biomarker. The stratified classification strategy combining molecular and immune subtypes provides valuable insights for future clinical practice.
Keyphrases
  • copy number
  • endometrial cancer
  • mitochondrial dna
  • clinical practice
  • genome wide
  • deep learning
  • dna methylation
  • single cell
  • gene expression
  • current status